Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kent

Showing results (1021-1030 of 1,075) with videos related to

Pageof 108
Sort By:
The American Journal of Cardiology|February 24, 2009
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stentsMichael A Gaglia, Daniel H Steinberg, Tina L Pinto Slottow, et al.
Nature Cardiovascular Research|June 7, 2024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular riskRozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, et al.
The American Journal of Cardiology|October 24, 2006
Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysisSang-Wook Kim, Gary S Mintz, Patrick Ohlmann, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?Asmir I Syed, Amit Kakkar, Amit Karkar, et al.
JACC. Cardiovascular Interventions|November 20, 2010
Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patientsItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|March 10, 2010
Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacementItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|July 8, 2008
Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectorisDaniel H Steinberg, Palak Shah, Tim Kinnaird, et al.
Annals of Internal Medicine|November 12, 2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and ElaborationDavid M Kent, David van Klaveren, Jessica K Paulus, et al.
Annals of Internal Medicine|November 12, 2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) StatementDavid M Kent, Jessica K Paulus, David van Klaveren, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Pageof 108

Showing results (1021-1030 of 1,075) with videos related to

Sort By:
Pageof 108
The American Journal of Cardiology|February 24, 2009
Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stentsMichael A Gaglia, Daniel H Steinberg, Tina L Pinto Slottow, et al.
Nature Cardiovascular Research|June 7, 2024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular riskRozalina G McCoy, Jeph Herrin, Kavya Sindhu Swarna, et al.
The American Journal of Cardiology|October 24, 2006
Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysisSang-Wook Kim, Gary S Mintz, Patrick Ohlmann, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?Asmir I Syed, Amit Kakkar, Amit Karkar, et al.
JACC. Cardiovascular Interventions|November 20, 2010
Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patientsItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|March 10, 2010
Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacementItsik Ben-Dor, Augusto D Pichard, Lowell F Satler, et al.
The American Journal of Cardiology|July 8, 2008
Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectorisDaniel H Steinberg, Palak Shah, Tim Kinnaird, et al.
Annals of Internal Medicine|November 12, 2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and ElaborationDavid M Kent, David van Klaveren, Jessica K Paulus, et al.
Annals of Internal Medicine|November 12, 2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) StatementDavid M Kent, Jessica K Paulus, David van Klaveren, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Pageof 108